Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Saran

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 17, 2006
Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004Hermann L Müller, Assunta Albanese, Gabriele Calaminus, et al.
Asia-Pacific Journal of Clinical Oncology|March 26, 2026
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-OncologyMark B Pinkham, Hao-Wen Sim, Rosalind L Jeffree, et al.
Future Oncology (London, England)|June 21, 2014
Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?Alba A Brandes, Warren Mason, Josef Pichler, et al.
Neuro-Oncology|January 27, 2016
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapyFrank Saran, Olivier L Chinot, Roger Henriksson, et al.
Neuro-Oncology|March 24, 2016
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglioOlivier L Chinot, Ryo Nishikawa, Warren Mason, et al.
Neuro-Oncology|August 13, 2016
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastomaWolfgang Wick, Olivier L Chinot, Martin Bendszus, et al.
Journal of Medical Imaging and Radiation Oncology|July 28, 2020
Quality improvement in paediatric radiation oncology through peer reviewLaura Murphy, Jessica Cantwell, Jennifer Chard, et al.
Neuro-Oncology|March 6, 2013
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseGabriele Calaminus, Rolf Kortmann, Jennifer Worch, et al.
Journal of Medical Imaging and Radiation Oncology|December 25, 2023
Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and ResearchJeremy Khong, Hui Tee, Peter Gorayski, et al.
International Journal of Cancer|May 3, 2017
Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapyMatthew J Murray, Shivani Bailey, Katja Heinemann, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 17, 2006
Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004Hermann L Müller, Assunta Albanese, Gabriele Calaminus, et al.
Asia-Pacific Journal of Clinical Oncology|March 26, 2026
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-OncologyMark B Pinkham, Hao-Wen Sim, Rosalind L Jeffree, et al.
Future Oncology (London, England)|June 21, 2014
Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?Alba A Brandes, Warren Mason, Josef Pichler, et al.
Neuro-Oncology|January 27, 2016
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapyFrank Saran, Olivier L Chinot, Roger Henriksson, et al.
Neuro-Oncology|March 24, 2016
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglioOlivier L Chinot, Ryo Nishikawa, Warren Mason, et al.
Neuro-Oncology|August 13, 2016
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastomaWolfgang Wick, Olivier L Chinot, Martin Bendszus, et al.
Journal of Medical Imaging and Radiation Oncology|July 28, 2020
Quality improvement in paediatric radiation oncology through peer reviewLaura Murphy, Jessica Cantwell, Jennifer Chard, et al.
Neuro-Oncology|March 6, 2013
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseGabriele Calaminus, Rolf Kortmann, Jennifer Worch, et al.
Journal of Medical Imaging and Radiation Oncology|December 25, 2023
Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and ResearchJeremy Khong, Hui Tee, Peter Gorayski, et al.
International Journal of Cancer|May 3, 2017
Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapyMatthew J Murray, Shivani Bailey, Katja Heinemann, et al.
Pageof 8